Initial Report on Differential Expression of Sprouty Proteins 1 and 2 in Human Epithelial Ovarian Cancer Cell Lines
Sprouty (Spry) proteins, modulators of receptor tyrosine kinase signaling pathways, have been shown to be deregulated in a variety of pathological conditions including cancer. In the present study we investigated the expression of Spry1 and Spry2 isoforms in a panel of human ovarian cancer cell line...
Main Authors: | Samar Masoumi Moghaddam, Afshin Amini, Ai-Qun Wei, Mohammad Hossein Pourgholami, David Lawson Morris |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Journal of Oncology |
Online Access: | http://dx.doi.org/10.1155/2012/373826 |
Similar Items
-
Utility of Vascular Endothelial Growth Factor Inhibitors in the Treatment of Ovarian Cancer: From Concept to Application
by: Afshin Amini, et al.
Published: (2012-01-01) -
Role of receptor tyrosine kinase regulator Sprouty in ovarian cancer cells
by: So, Wai Kin
Published: (2012) -
Role of receptor tyrosine kinase regulator Sprouty in ovarian cancer cells
by: So, Wai Kin
Published: (2012) -
Role of receptor tyrosine kinase regulator Sprouty in ovarian cancer cells
by: So, Wai Kin
Published: (2012) -
Hypoxia inducible factors regulate the transcription of the sprouty2 gene and expression of the sprouty2 protein.
by: Xianlong Gao, et al.
Published: (2017-01-01)